This study is looking at how well a laser procedure called Direct Selective Laser Trabeculoplasty (DSLT) works for people with glaucoma who haven't been treated yet. Glaucoma is an eye condition that can cause vision loss due to high pressure inside the eye (intraocular pressure or IOP). DSLT uses a laser to help fluid drain better from your eye, which can lower IOP. The goal of this study is to see if DSLT can reduce your IOP by more than 20% without needing daily eye drops or other medications, 6 months after the procedure. This study is for adults aged 18 and older with primary open-angle glaucoma or ocular hypertension.

Study design

This is an observational study involving 60 participants. It is not specified if participants are randomly assigned to groups or if the study is blinded.

What's involved

Eligible participants will undergo the DSLT procedure. The study will measure the reduction in your eye pressure at 6 months.

Compensation

Not stated in the trial record.

Follow-up

Your eye pressure will be measured 6 months after the DSLT procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.